| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192805 | Annals of Allergy, Asthma & Immunology | 2010 | 5 Pages |
Abstract
Glatiramer acetate offers significant benefit to patients with multiple sclerosis. Our experience suggests that patients who suspend its use owing to local or systemic reactions can be successfully and safely desensitized and can resume medication use. To our knowledge, this is the first report of successful desensitization to glatiramer acetate in patients with multiple sclerosis.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Sonia N. MD, Fred H. MD, Mary R. MD, Cristine MD, Hary T. MD, S. Rubina MD, David M. MD,